For ENT
& family
medicine.

The nasal cavity has emerged as a significant reservoir for opportunistic pathogens, which can lead to various respiratory conditions, including allergic rhinitis, chronic rhinosinusitis, asthma, pneumonia, and otitis media.

The nasal cavity is a primary defense against environmental threats. It houses commensal bacteria that suppress harmful pathogen colonization.

Beyond the traditional methods of managing nasal health, a novel approach has emerged: the immune-modulating nasal spray. This innovative technology is designed to enhance the body's natural defenses right at the gateway of respiratory health.

The clinical guideline for acute sinusitis suggests a waiting period of three days before initiating treatment. However, evidence shows that a virus typically takes about 48 hours to become viable. This discrepancy prompts questions about the effectiveness of the current approach.

The default management path for chronic rhinosinusitis has leaned on antibiotic courses and corticosteroid sprays. Neither addresses the underlying immune ecology of the nasal cavity.

The common cold and flu are primarily caused by viruses that enter the body through the nasal passages. Nasal immune modulation offers a targeted approach to enhance the body's natural defenses right at this entry point.

An evidence-based recommendation for treating rhinosinusitis in adults presenting to ENT specialists and family doctors.

Antibiotics have saved countless lives, but unintended side effects exist. Infants exposed to antibiotics show increased susceptibility to diseases later in life. Antibiotics disrupt the balance of the developing microbiota.